214665 Finsbury WWP pp37-pp50 6 15 09 1:30 PM Page 39 Finsbury Worldwide Pharmaceutical Trust PLC Annual Report 2009 39 Notes to the Financial Statements continued 1.
ACCOUNTING POLICIES CONTINUED Rate of exchange against sterling at 31 March 2009 2008 U. S. dollar 1.4334 1.9875 Japanese yen 141.5720 197.8260 Swiss franc 1.6298 1.9658 Euros 1.0796 1.2543 2.
INCOME FROM INVESTMENTS HELD AT FAIR VALUE THROUGH PROFIT OR LOSS 2009 2008 000 000 Income from investments UK listed dividends 212 3 Overseas dividends 3,594 3,029 Money market dividend 48 144 Fixed interest income 71 3,925 3,176 Other income Interest receivable 93 228 Total income from investments held at fair value through profit or loss 4,018 3,404 Total income comprises: Dividends 3,854 3,176 Interest 164 228 4,018 3,404 3.
INVESTMENT MANAGEMENT, MANAGEMENT AND PERFORMANCE FEES 2009 2009 2009 2008 2008 2008 Revenue Capital Total Revenue Capital Total 000 000 000 000 000 000 Investment Management fee 83 1,584 1,667 84 1,607 1,691 Management fee 33 628 661 38 716 754 Performance fee accrual 224 224 116 2,436 2,552 122 2,323 2,445 In accordance with the performance fee arrangements described in the Report of the Directors on pages 17 and 18 no performance fee was paid during the year 2008: nil.
At the year end a performance fee of 224,000 was accrued 2008: nil.
